2-216694661-G-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_000599.4(IGFBP5):​c.115C>T​(p.Pro39Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000059 in 1,526,490 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

IGFBP5
NM_000599.4 missense

Scores

14
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.48

Publications

0 publications found
Variant links:
Genes affected
IGFBP5 (HGNC:5474): (insulin like growth factor binding protein 5) Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]
TESHL (HGNC:52740): (testicular germ cell expressed HSF2 interacting lncRNA)
IGFBP-AS1 (HGNC:55655): (IGFBP5 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAdExome4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGFBP5NM_000599.4 linkc.115C>T p.Pro39Ser missense_variant Exon 1 of 4 ENST00000233813.5 NP_000590.1 P24593
IGFBP-AS1NR_187138.1 linkn.216G>A non_coding_transcript_exon_variant Exon 1 of 6
IGFBP-AS1NR_187139.1 linkn.216G>A non_coding_transcript_exon_variant Exon 1 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGFBP5ENST00000233813.5 linkc.115C>T p.Pro39Ser missense_variant Exon 1 of 4 1 NM_000599.4 ENSP00000233813.4 P24593

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152202
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
138656
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000364
AC:
5
AN:
1374288
Hom.:
0
Cov.:
31
AF XY:
0.00000444
AC XY:
3
AN XY:
676408
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29146
American (AMR)
AF:
0.00
AC:
0
AN:
32650
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35624
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73380
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5494
European-Non Finnish (NFE)
AF:
0.00000280
AC:
3
AN:
1072238
Other (OTH)
AF:
0.0000353
AC:
2
AN:
56658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41446
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.00000853
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 24, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.115C>T (p.P39S) alteration is located in exon 1 (coding exon 1) of the IGFBP5 gene. This alteration results from a C to T substitution at nucleotide position 115, causing the proline (P) at amino acid position 39 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Uncertain
0.035
T
BayesDel_noAF
Benign
-0.19
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
T;.
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Uncertain
0.095
D
MetaRNN
Uncertain
0.44
T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Uncertain
2.8
M;.
PhyloP100
5.5
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-2.6
D;N
REVEL
Benign
0.28
Sift
Uncertain
0.015
D;D
Sift4G
Uncertain
0.026
D;D
Polyphen
0.63
P;.
Vest4
0.35
MVP
0.65
MPC
1.7
ClinPred
0.99
D
GERP RS
3.6
PromoterAI
-0.068
Neutral
Varity_R
0.23
gMVP
0.82
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779879411; hg19: chr2-217559384; API